
Xtandi Enzalutamide 40 Mg
Bottle
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
What is Enzalutamide Used For?
- Enzalutamide is used for:
- Metastatic Castration-Resistant Prostate Cancer (mCRPC) – Both chemotherapy-naïve and post-chemotherapy
- Non-Metastatic CRPC – High-risk patients with rising PSA despite hormonal therapy
- Metastatic Castration-Sensitive Prostate Cancer – Newly diagnosed metastatic disease
How Does Enzalutamide Work?
- Enzalutamide is an androgen receptor inhibitor, which:
- Competitively inhibits androgen binding to androgen receptors
- Prevents androgen receptor nuclear translocation
- Inhibits androgen receptor-mediated DNA binding and transcription
How to Use Enzalutamide
Dosage: 160mg (four 40mg capsules) once daily
Administration: Take orally with or without food; swallow capsules whole
Precaution: Monitor for seizures (contraindicated in patients with seizure history); avoid strong CYP2C8 inhibitors; oncologist supervision mandatory
Side Effects of Enzalutamide
Common Side Effects: Fatigue, hot flashes, hypertension, diarrhea, dizziness, headache
Serious Side Effects (seek medical help): Seizures, falls and fractures, posterior reversible encephalopathy syndrome (PRES), ischemic heart disease
Benefits
- Next-generation AR inhibitor — blocks androgen binding, nuclear translocation, and DNA transcription simultaneously
- More complete androgen blockade than first-generation antiandrogens (bicalutamide, flutamide)
- Demonstrated survival benefit in mCRPC (PREVAIL, AFFIRM trials) and mCSPC (ARCHES, ENZAMET trials)
- Oral once-daily dosing (four 40mg capsules) — convenient outpatient treatment
- Delays metastasis development in high-risk non-metastatic CRPC (PROSPER trial)
Warnings and Precautions
- Seizure risk (~1%): contraindicated in patients with history of seizures or conditions that lower seizure threshold
- Falls and fractures: higher risk in elderly patients — bone density monitoring and calcium/vitamin D supplementation recommended
- Hypertension: monitor blood pressure regularly; antihypertensive therapy may be required
- Posterior reversible encephalopathy syndrome (PRES): seek immediate care for headache, confusion, or vision changes
- Strong CYP3A4 inducer: reduces plasma levels of many co-administered drugs (warfarin, statins, tacrolimus) — comprehensive medication review required
- Embryo-fetal toxicity: not for use in women; male patients with female partners of childbearing potential should use contraception
Drug Interactions
- Strong CYP2C8 inhibitors (gemfibrozil): increase Enzalutamide exposure — avoid combination
- CYP3A4 substrates (warfarin, cyclosporine, midazolam): Enzalutamide significantly reduces their plasma levels — monitor and adjust doses
- Strong CYP3A4 inducers (rifampicin): reduce Enzalutamide levels — avoid if possible
- Drugs that lower seizure threshold: additive seizure risk — avoid combination
Storage Information
- Store at room temperature 20°C–25°C in original container; protect from moisture
- Keep out of reach of children
- Do not use after expiry date
Frequently Asked Questions
Q1: What is Xtandi Enzalutamide 40mg used for?
Enzalutamide treats metastatic castration-resistant prostate cancer (mCRPC), non-metastatic CRPC with rising PSA, and metastatic castration-sensitive prostate cancer — covering multiple stages of hormone-sensitive disease.
Q2: How does Enzalutamide work?
Enzalutamide is a next-generation androgen receptor inhibitor. It blocks androgen binding to the AR, prevents the AR from moving to the cell nucleus, and inhibits AR-mediated DNA transcription — blocking all androgen signaling steps simultaneously.
Q3: How is Enzalutamide (Xtandi) taken?
Take 160mg once daily as four 40mg capsules, with or without food. Swallow capsules whole. Take at the same time each day.
Q4: Why is seizure risk important with Enzalutamide?
Enzalutamide has a seizure risk of approximately 1% due to its CNS activity. It is contraindicated in patients with a history of seizures. Inform your oncologist of any seizure history, brain injury, or concurrent medications that lower the seizure threshold.
Q5: How long is Enzalutamide treatment continued?
Treatment continues until disease progression or unacceptable toxicity. PSA and imaging are monitored regularly. In non-metastatic CRPC, treatment continues until metastasis or PSA progression.
Q6: What are the most common side effects?
Common side effects include fatigue, hot flashes, hypertension, diarrhea, dizziness, and headache. Cognitive effects (memory, concentration) can occur in some patients.
Q7: What serious side effects require emergency care?
Seek immediate care for: seizures, falls and fractures (especially in older patients), signs of posterior reversible encephalopathy syndrome (PRES — headache, confusion, vision changes), or significant cardiovascular events.
Q8: Does Enzalutamide interact with other drugs?
Enzalutamide is a strong CYP3A4 inducer and can significantly reduce levels of many drugs including warfarin, tacrolimus, and some statins. It also inhibits CYP2C8. A comprehensive medication review is essential before starting.
Q9: Can Enzalutamide be taken with food?
Yes, it can be taken with or without food. Consistent dosing timing is important. Avoid CYP3A4 inducers (rifampicin) and inhibitors (ketoconazole) without medical review.
Q10: Is Enzalutamide safe for older patients?
Older patients have higher rates of falls and fractures. Bone health monitoring (DXA scan) and fall prevention measures are important. Regular neurological assessment for cognitive effects is also recommended.
Q11: What monitoring tests are needed?
Regular PSA testing, imaging to assess response, blood pressure monitoring, and liver function tests are required. Bone mineral density should be assessed given the risk of fractures.
Q12: Is a prescription required for Enzalutamide?
Yes. Enzalutamide is a prescription-only oncology medication that requires specialist prescribing, molecular staging of prostate cancer, and regular monitoring throughout treatment.
Customer Reviews
Dr. Elena Petrov
Germany · 1 month ago
“Received Bevacizumab injection vials for clinic use. All vials sealed, batch numbers verified with manufacturer. Good supplier.”
Dr. Priya Nair
India · 2 months ago
“Sourced Nivolumab for a clinical case. Vials arrived cold-packed and within specification. Documentation was thorough.”
Dr. Charles Monroe
USA · 4 months ago
“Sourced Enzalutamide for prostate cancer patients. Medionix handled the order professionally with full documentation.”
Dr. Elena Petrov
Germany · 1 month ago
“Received Bevacizumab injection vials for clinic use. All vials sealed, batch numbers verified with manufacturer. Good supplier.”
Dr. Priya Nair
India · 2 months ago
“Sourced Nivolumab for a clinical case. Vials arrived cold-packed and within specification. Documentation was thorough.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.





